osteoporosis screening guidelines Topical Map Library Entry
Open this free osteoporosis screening guidelines topical map from the library to plan topic clusters, pillar pages, article ideas, content briefs, prompt kits, and publishing order for SEO.
Built for SEOs, agencies, bloggers, and content teams that need a practical content plan for Google rankings, AI Overview eligibility, and LLM citation.
Use this map in your content workflow
Copy the article plan into a brief, spreadsheet, or client roadmap. The export keeps group, order, article title, intent, priority, target query, and summary together.
1. Screening & Risk Assessment
Covers guideline-driven screening recommendations, risk-assessment tools (FRAX), and clinical criteria for who should receive DXA. This is foundational because proper screening determines who benefits from testing and treatment.
Osteoporosis Screening Guidelines: Who to Test, When to Use FRAX, and How to Decide on DXA
A comprehensive, guideline-aligned reference comparing USPSTF, NOF, Endocrine Society and specialty guidance on osteoporosis screening. Explains FRAX use, thresholds for DXA testing, screening intervals, and a primary-care algorithm so clinicians can make evidence-based, reproducible screening decisions.
How to Use FRAX to Decide Who Needs a DXA Scan
Step-by-step guide to calculating FRAX, interpreting 10-year fracture risk, adjusting for secondary causes and glucocorticoid dose, and concrete FRAX cutoffs to trigger DXA or treatment.
USPSTF Osteoporosis Screening Recommendations Explained
Plain-language breakdown of the USPSTF statement: who is screened, age thresholds, evidence basis, and how to apply it in practice.
When to Screen Men, Premenopausal Women, and Younger Adults
Guidance for populations not covered by routine screening: men, premenopausal women, people on androgen deprivation therapy, and younger adults with risk factors.
Secondary Causes of Low Bone Density That Mandate Earlier Testing
List and explanation of medical conditions and medications (e.g., glucocorticoids, hyperparathyroidism, malabsorption) that should prompt expedited DXA screening.
Practical Primary-Care Screening Algorithm for Osteoporosis
Ready-to-use algorithm with decision nodes (age, risk factors, FRAX thresholds) and quick referral/action steps for busy clinicians.
2. DEXA Scan Acquisition & Quality
Explains how DXA/DEXA scans are performed, machine types, ideal acquisition, VFA technique, and quality assurance to ensure reliable BMD measurements.
DEXA Scanning: How DEXA Works, How It's Performed, and How to Ensure High-Quality, Reproducible Results
Technical and practical guide to DXA acquisition: physics principles, standard scanning sites (lumbar spine, hip, forearm), patient preparation and positioning, VFA technique, and QA/calibration protocols to minimize measurement error and machine-to-machine variability.
DXA vs Quantitative CT vs Ultrasound: When to Use Each Modality
Comparison of modalities—strengths, limitations, clinical contexts where each is preferred (e.g., QCT for trabecular BMD, limited value of ultrasound for diagnosis).
How to Prepare and Position Patients for Accurate Lumbar Spine and Hip DXA
Stepwise preparation and positioning instructions, checklists for technologists, and tips to reduce artifacts and repeat scans.
Vertebral Fracture Assessment (VFA) with DXA: Technique, Indications, and Pitfalls
When to perform VFA, how to acquire and score vertebral images, comparison with radiography, and common interpretation pitfalls.
Quality Assurance and Cross-Calibration: Keeping DXA Results Reliable Over Time
QA program components, phantom scanning, frequency of calibration, how to handle software upgrades and machine replacement to preserve comparability.
Radiation Dose, Safety, and Contraindications for DXA
Quantifies DXA radiation exposure, addresses safety in pregnancy and repeated testing, and provides counseling language for patients.
3. DEXA Interpretation & Reporting
Focused, authoritative guidance on interpreting DXA results: T- and Z-scores, ISCD diagnostic criteria, handling discordance and artifacts, and producing high-quality clinical reports.
Interpreting DXA: T-scores, Z-scores, Artifacts, Discordance, and Best-Practice Reporting (ISCD Standards)
An exhaustive clinician guide that explains what T- and Z-scores mean, how to apply ISCD diagnostic criteria, manage discordant spine vs hip results, recognize and correct for artifacts (degenerative disease, vascular calcification, hardware), and templates for clear, actionable DXA reports.
T-score vs Z-score: Which to Use, How They’re Calculated, and Diagnostic Thresholds
Explains the statistical basis of T- and Z-scores, age- and sex-based norms, and clinical situations dictating which score to use for diagnosis and monitoring.
Managing Discordant Spine and Hip DXA Results: A Practical Approach
Decision framework for when spine and hip scores disagree: evaluate artifacts, consider alternative sites, use clinical context and FRAX to guide diagnosis/treatment.
Common Artifacts on DXA and How They Affect Scores (Degenerative Change, Aortic Calcification, Hardware)
Illustrative examples of artifacts, how they bias BMD readings, and stepwise correction/interpretation strategies to avoid misdiagnosis.
Interpreting DXA in Patients with Fragility Fractures but Non-Osteoporotic BMD
Explains reasons fractures can occur despite BMD above osteoporotic thresholds and how to incorporate fracture history into treatment decisions.
DXA Report Templates and Sample Reports for Clinicians
Ready-to-adopt report templates and wording for radiology/clinical reports that include diagnosis, recommendations, FRAX, and follow-up interval.
Coding and Reimbursement for DXA and VFA (CPT/ICD Guidance)
Practical overview of CPT codes, ICD-10 coding tips, modifiers, and payer considerations for ordering DXA and VFA.
4. Management Decisions & Monitoring
Translates DXA results into clinical action: thresholds for treatment, medication selection, monitoring intervals, and how to interpret longitudinal changes in BMD.
From DXA to Decision: Treatment Thresholds, Medication Selection, Monitoring Intervals, and Interpreting Change in Bone Density
Clinical guide linking DXA and FRAX outputs to intervention: when to start pharmacologic therapy, first-line drug choices, management of side effects and drug holidays, and evidence-based protocols for repeating DXA and assessing response (least significant change).
Using FRAX and DXA Together to Decide on Treatment
Practical examples and thresholds showing how FRAX probabilities plus site-specific DXA results determine treatment candidacy.
Pharmacologic Therapies for Osteoporosis: Bisphosphonates, Denosumab, PTH Analogs, SERMs — Indications and Monitoring
Detailed clinical guide comparing drug classes, selection based on fracture risk and comorbidity, initiation and monitoring protocols, and management of adverse events (e.g., ONJ, atypical femoral fracture).
When and How to Repeat DXA: Interpreting Meaningful Change and Least Significant Change (LSC)
Explains statistical LSC, how to calculate it for a site/machine, recommended intervals for monitoring on and off therapy, and examples of clinical decision-making based on change.
Managing Patients Stopping Denosumab or Bisphosphonates
Guidance on rebound risk after denosumab discontinuation, sequencing therapies, and strategies to mitigate fracture risk when stopping treatment.
Non-Pharmacologic Management: Nutrition, Exercise, and Fall Prevention
Evidence-based recommendations on calcium and vitamin D, resistance and balance exercise programs, home-safety assessments, and multifactorial fall prevention.
5. Special Populations & Complex Cases
Addresses interpretation and management nuances in men, premenopausal women, patients on glucocorticoids or cancer therapy, CKD, and other complex clinical scenarios where DXA has limitations.
DXA and Osteoporosis in Special Populations: Men, Premenopausal Women, Glucocorticoid-Induced Osteoporosis, CKD, and Cancer-Therapy–Related Bone Loss
Focused coverage of interpretation and management differences in atypical populations: when to use Z-scores, how FRAX differs in men, approaches to glucocorticoid-induced bone loss and cancer-therapy bone loss, and limitations of DXA in CKD and other metabolic bone diseases.
Interpreting DXA and Managing Osteoporosis in Men (Including ADT Patients)
Covers when to screen men, how reference ranges and FRAX apply, and management nuances for androgen-deprivation therapy and hypogonadism-related bone loss.
Glucocorticoid-Induced Osteoporosis: Screening, Prevention, and Treatment
Risk stratification and early intervention pathways for patients on chronic glucocorticoids, including when to start prophylactic therapy and monitoring recommendations.
Interpreting DXA in Premenopausal Women and When to Use Z-scores
Criteria for diagnosing low bone density in premenopausal women, appropriate use of Z-scores, and when to investigate secondary causes.
Osteoporosis, DXA and Chronic Kidney Disease: What Changes and What Alternative Tests to Consider
Explains the limitations of DXA in CKD-MBD, when bone biopsy or bone turnover markers are indicated, and how to manage fracture risk in advanced CKD.
Cancer-Therapy–Related Bone Loss: Monitoring and Prevention (Aromatase Inhibitors, ADT)
Screening schedules, thresholds to start therapy, and specific considerations for patients receiving aromatase inhibitors or androgen-deprivation therapy.
Content strategy and topical authority plan for Osteoporosis screening and DEXA interpretation
The recommended SEO content strategy for Osteoporosis screening and DEXA interpretation is the hub-and-spoke topical map model: one comprehensive pillar page on Osteoporosis screening and DEXA interpretation, supported by cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on Osteoporosis screening and DEXA interpretation.
Pillar
Start with the core guide
Clusters
Follow grouped article themes
Priority
Publish strongest opportunities first
Sequence
Use the recommended order
Search intent coverage across Osteoporosis screening and DEXA interpretation
This topical map covers the full intent mix needed to build authority, not just one article type.
Entities and concepts to cover in Osteoporosis screening and DEXA interpretation
Publishing order
Start with the pillar page, then publish the high-priority articles first to establish coverage around osteoporosis screening guidelines faster.
Use the recommended sequence as the content calendar foundation.